At the Heart of Diabetes

Best Practice, PCCS
Europe/London GMT+1

Description

Cardiovascular disease is the leading cause of death in people living with type 2 diabetes.

 

Since concerns were highlighted with rosiglitazone, it was made mandatory for all new diabetes drugs to prove their cardiovascular safety. Somewhat unexpectedly, not only was cardiovascular safety established with certain newer diabetes drugs but also cardiovascular superiority compared to placebo i.e. significant reductions in major adverse cardiovascular events.

 

This webinar will summarise key take-home messages from all the published diabetes cardiovascular outcome studies to date, how these studies have changed guidelines and what the implications are for primary care.

 

Delivery of this webinar is supported by Data4NHS.

 

Co-produced by Best Practice and PCCS.

At the Heart of Diabetes

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Kevin Fernando

 

Link to the Event

Banner to the Event

At the Heart of Diabetes
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"